Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 37.65 CNY 0.94% Market Closed
Market Cap: 34.8B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

Intrinsic Value

The intrinsic value of one Livzon Pharmaceutical Group Inc stock under the Base Case scenario is 47.94 CNY. Compared to the current market price of 37.65 CNY, Livzon Pharmaceutical Group Inc is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
47.94 CNY
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Livzon Pharmaceutical Group Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Livzon Pharmaceutical Group Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Livzon Pharmaceutical Group Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

37.65 CNY
+0.94%
+0.94%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Livzon Pharmaceutical Group Inc
CN
Pharmaceuticals
Market Cap
34.8B CNY
IPO
Oct 28, 1993
Employees
8 580
China
Market Cap
34.8B CNY
Industry
Pharmaceuticals
IPO
Oct 28, 1993
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Livzon Pharmaceutical Group Inc

Provide an overview of the primary business activities
of Livzon Pharmaceutical Group Inc.

What unique competitive advantages
does Livzon Pharmaceutical Group Inc hold over its rivals?

What risks and challenges
does Livzon Pharmaceutical Group Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Livzon Pharmaceutical Group Inc.

Provide P/S
for Livzon Pharmaceutical Group Inc.

Provide P/E
for Livzon Pharmaceutical Group Inc.

Provide P/OCF
for Livzon Pharmaceutical Group Inc.

Provide P/FCFE
for Livzon Pharmaceutical Group Inc.

Provide P/B
for Livzon Pharmaceutical Group Inc.

Provide EV/S
for Livzon Pharmaceutical Group Inc.

Provide EV/GP
for Livzon Pharmaceutical Group Inc.

Provide EV/EBITDA
for Livzon Pharmaceutical Group Inc.

Provide EV/EBIT
for Livzon Pharmaceutical Group Inc.

Provide EV/OCF
for Livzon Pharmaceutical Group Inc.

Provide EV/FCFF
for Livzon Pharmaceutical Group Inc.

Provide EV/IC
for Livzon Pharmaceutical Group Inc.

Show me price targets
for Livzon Pharmaceutical Group Inc made by professional analysts.

What are the Revenue projections
for Livzon Pharmaceutical Group Inc?

How accurate were the past Revenue estimates
for Livzon Pharmaceutical Group Inc?

What are the Net Income projections
for Livzon Pharmaceutical Group Inc?

How accurate were the past Net Income estimates
for Livzon Pharmaceutical Group Inc?

What are the EPS projections
for Livzon Pharmaceutical Group Inc?

How accurate were the past EPS estimates
for Livzon Pharmaceutical Group Inc?

What are the EBIT projections
for Livzon Pharmaceutical Group Inc?

How accurate were the past EBIT estimates
for Livzon Pharmaceutical Group Inc?

Compare the revenue forecasts
for Livzon Pharmaceutical Group Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Livzon Pharmaceutical Group Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Livzon Pharmaceutical Group Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Livzon Pharmaceutical Group Inc compared to its peers.

Compare the P/E ratios
of Livzon Pharmaceutical Group Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Livzon Pharmaceutical Group Inc with its peers.

Analyze the financial leverage
of Livzon Pharmaceutical Group Inc compared to its main competitors.

Show all profitability ratios
for Livzon Pharmaceutical Group Inc.

Provide ROE
for Livzon Pharmaceutical Group Inc.

Provide ROA
for Livzon Pharmaceutical Group Inc.

Provide ROIC
for Livzon Pharmaceutical Group Inc.

Provide ROCE
for Livzon Pharmaceutical Group Inc.

Provide Gross Margin
for Livzon Pharmaceutical Group Inc.

Provide Operating Margin
for Livzon Pharmaceutical Group Inc.

Provide Net Margin
for Livzon Pharmaceutical Group Inc.

Provide FCF Margin
for Livzon Pharmaceutical Group Inc.

Show all solvency ratios
for Livzon Pharmaceutical Group Inc.

Provide D/E Ratio
for Livzon Pharmaceutical Group Inc.

Provide D/A Ratio
for Livzon Pharmaceutical Group Inc.

Provide Interest Coverage Ratio
for Livzon Pharmaceutical Group Inc.

Provide Altman Z-Score Ratio
for Livzon Pharmaceutical Group Inc.

Provide Quick Ratio
for Livzon Pharmaceutical Group Inc.

Provide Current Ratio
for Livzon Pharmaceutical Group Inc.

Provide Cash Ratio
for Livzon Pharmaceutical Group Inc.

What is the historical Revenue growth
over the last 5 years for Livzon Pharmaceutical Group Inc?

What is the historical Net Income growth
over the last 5 years for Livzon Pharmaceutical Group Inc?

What is the current Free Cash Flow
of Livzon Pharmaceutical Group Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Livzon Pharmaceutical Group Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Livzon Pharmaceutical Group Inc

Current Assets 17.5B
Cash & Short-Term Investments 11.6B
Receivables 3.8B
Other Current Assets 2.1B
Non-Current Assets 8.1B
Long-Term Investments 1.7B
PP&E 4.7B
Intangibles 850.8m
Other Non-Current Assets 801.4m
Current Liabilities 9.7B
Accounts Payable 631.2m
Accrued Liabilities 350.6m
Short-Term Debt 3B
Other Current Liabilities 5.8B
Non-Current Liabilities 2B
Long-Term Debt 722.1m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Livzon Pharmaceutical Group Inc

Revenue
11.9B CNY
Cost of Revenue
-4.2B CNY
Gross Profit
7.6B CNY
Operating Expenses
-5B CNY
Operating Income
2.6B CNY
Other Expenses
-561m CNY
Net Income
2B CNY

Free Cash Flow Analysis
Livzon Pharmaceutical Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
59/100
Profitability
Score

Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Livzon Pharmaceutical Group Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
68/100
Solvency
Score

Livzon Pharmaceutical Group Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Livzon Pharmaceutical Group Inc

Wall Street analysts forecast Livzon Pharmaceutical Group Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Livzon Pharmaceutical Group Inc is 40.34 CNY with a low forecast of 31.76 CNY and a high forecast of 48.83 CNY.

Lowest
Price Target
31.76 CNY
16% Downside
Average
Price Target
40.34 CNY
7% Upside
Highest
Price Target
48.83 CNY
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Livzon Pharmaceutical Group Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Livzon Pharmaceutical Group Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Livzon Pharmaceutical Group Inc stock?

The intrinsic value of one Livzon Pharmaceutical Group Inc stock under the Base Case scenario is 47.94 CNY.

Is Livzon Pharmaceutical Group Inc stock undervalued or overvalued?

Compared to the current market price of 37.65 CNY, Livzon Pharmaceutical Group Inc is Undervalued by 21%.

Back to Top